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ABSTRACT 
 
Recent scientific research has indicated that inflammation in adipose tissues plays a 
central role in the pathophysiology of obesity and related complications. However, 
despite extensive studies, the molecular mechanisms that trigger and aggravate the 
obesity-related inflammation remain unclear. In this study, transcriptome profiling of 
omental adipose tissues from three obese and four lean patients was performed using the 
RNA-Seq technology. Differential expression analysis identified 206 dysregulated 
genes (p-value < 0.05 and fold change ≥ 2) in obesity, that are known to be involved in 
a multitude of functions including stress response, inflammatory response and leukocyte 
adhesion. Furthermore, differential splicing analysis uncovered a possible role for TLR4 
RNA splicing in obesity, which is further validated with an independent cohort of 
samples (five obese and six lean patients) using RT-qPCR. These findings suggest that, 
as a person experiences weight gain leading to obesity, the adipose splicing pattern of 
TLR4 transcripts changes in favor of activation of TLR4 signaling, which in turn, may 
contribute to the progression of obesity-related inflammation and complications. This 
study provides a glimpse at the transcriptome of disease-state adipose tissue in obesity, 
and demonstrates the potential importance of aberrant RNA splicing and expression in 
obesity-associated immune dysregulation. 
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ABSTRAK 
 
Kajian saintifik baru-baru ini telah menjelaskan kepentingan keradangan tisu adipos 
dalam patofisiologi obesiti dan komplikasi yang berkaitan. Namun, mekanisme molekul 
yang mencetuskan dan menyulitkan keradangan metabolik masih tidak dapat difahami 
secara sepenuhnya. Kajian ini memprofilkan transkriptom tisu adipos (perut intra) 
daripada tiga orang pesakit obes dan empat orang pesakit kurus dengan penggunaan 
teknologi RNA-Seq. Analisis ekspresi mengenalpasti 206 gen dengan nilai p < 0.05 dan 
lipat perubahan ≥ 2; analisis pengayaan mendapati bahawa gen-gen tersebut terlibat 
dalam pelbagai fungsi, seperti tindak balas terhadap stres fisiologi/keradangan dan 
lekatan leukosit. Tambahan pula, analisis splicing alternatif menunjukkan bahawa 
splicing TLR4 memainkan peranan yang penting dalam obesiti; analisis RT-qPCR 
dengan 11 sampel tambahan (lima orang pesakit obes dan enam orang pesakit kurus) 
mengesahkan hasil kajian tersebut. Secara umumnya, analisis splicing alternatif ini 
menunjukkan perubahan trend splicing TLR4 apabila seseorang mengalami 
peningkatan berat badan/obesiti; perubahan ini mungkin mengaktifkan isyarat TLR4 
dan mengakibatkan perkembangan keradangan metabolik dalam tisu adipos. 
Kesimpulannya, kajian ini mendapati bahawa splicing alternatif dan ekspresi gen 
memainkan peranan penting dalam keradangan yang berkaitan dengan obesiti. 
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CHAPTER 1: INTRODUCTION 
 
Obesity is a medical condition characterized by accumulation of excess body fat to an 
extent that it may cause adverse effects to health. Approximately two billion adults 
worldwide were estimated to be either obese or overweight by 2008 (World Health 
Organization, 2014). Compared to the lean population, obese individuals are more prone 
to developing type 2 diabetes mellitus, hypertension, dyslipidemia, cardiovascular 
disease and other co-morbidities in the metabolic syndrome (Khaodhiar, McCowen, & 
Blackburn, 1999), leading to reduced life expectancy and increased economic burden 
for treating these disorders associated with obesity.  
 
The pathophysiology of obesity and related complications implicates both intra-organ 
and generalized metabolic and immune dysfunctions that are the result of many 
different interrelated and interactive molecular mechanisms. The white adipose tissue 
that forms the large majority of fat depots in the human body has been recognized as a 
major endocrine organ that secretes adipokines (Frühbeck, Gómez-Ambrosi, Muruzábal, 
& Burrell, 2001) besides fatty acids, lipids and proteins. The adipokines participate in a 
wide range of functions including the regulation of appetite, energy balance, insulin 
sensitivity, angiogenesis, blood pressure, inflammation and immune response (Kwon & 
Pessin, 2013; Trayhurn, 2013). In obese individuals, the key pathological features are an 
aberrant adipogenesis and lipolysis, the occurrence of inflammation in adipose tissue, 
the dysregulated expression of pro- and anti-inflammatory adipokines, and the induction 
of serum resistance. These pathological processes are believed to contribute to the 
development of obesity-associated maladies (Redinger, 2007).   
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Inflammation in adipose tissue is characterized by the infiltration of various immune 
cells which include macrophages, T cells and mast cells  (Altintas et al., 2011; Weisberg 
et al., 2003; Yang et al., 2010). Several contending hypotheses have been put forward to 
explain the development of inflammation. These include local hypoxia (Trayhurn, 2013), 
endoplasmic reticulum (ER) stress (Cnop, Foufelle, & Velloso, 2012) and oxidative 
stress (Bondia-Pons, Ryan, & Martinez, 2012). In all three conditions, dysregulated 
production of inflammatory adipokines has been observed (Bondia-Pons et al., 2012; 
Cnop et al., 2012; Trayhurn, 2013). More recently, it has also been shown that bacterial 
lipopolysaccharide (LPS) can trigger the low grade inflammation in human adipose 
tissue, leading to systemic insulin resistance (Mehta et al., 2010). LPS is the major 
structural component of the outer wall of all Gram-negative bacteria. It is recognized by 
toll-like receptor (TLR) 4 which interacts with extracellular proteins to induce a 
signaling cascade leading to the production of pro-inflammatory cytokines.  
 
The complex gene-environment interplay in the development of obesity is being 
intensively researched. Transcriptome profiling permits the identification of 
dysregulated genes in adipose tissue. In the last decade, cDNA microarray has been the 
instrument of choice for comparing transcriptome profiles in adipose tissues of obese 
and non-obese groups (Gómez-Ambrosi et al., 2004; Grant, Vester Boler, Ridge, 
Graves, & Swanson, 2011; Morton et al., 2011). Nonetheless, microarray technology 
has some drawbacks, such as low sensitivity and restriction to the examination of only 
known genes (Wang, Gerstein, & Snyder, 2009). These limitations became irrelevant 
with the introduction of next-generation sequencing technology. Specifically, whole-
transcriptome shotgun sequencing (RNA-Seq) allows millions of mRNA-derived cDNA 
molecules to be sequenced in parallel, without the need of bacterial clones; it also 
enables the detection of hitherto unknown transcripts and the generation of absolute 
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rather than relative gene-expression measurements (Wang et al., 2009). In addition, 
RNA-Seq can also detect changes in the splicing pattern of genes. Differential or 
alternative splicing generates multiple mRNA transcripts from a single gene to produce 
protein isoforms with different functions. Emerging evidence has suggested that the 
abnormal regulation of alternative splicing can result in the development of obesity and 
insulin resistance (Kaminska & Pihlajamäki, 2013).  
 
In the present study, omental adipose tissues from obese and lean individuals were 
subjected to RNA-Seq for transcriptome profiling. Omental adipose tissue was selected 
because fat from this depot has been shown to be more closely related to the co-
morbidities of obesity than fat from the subcutaneous depot (Montague & O’Rahilly, 
2000). 
 
The objectives of this study were: (i) to identify differentially spliced and expressed 
genes from omental adipose tissue of obese patients, in reference to the lean 
counterpart; and (ii) to derive new biological insights into the pathophysiology of 
obesity from the list of identified genes with alternative splicing and differential 
expression patterns.  
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CHAPTER 2: LITERATURE REVIEW 
 
2.1 The Obesity Epidemic 
Obesity is a disease characterized by accumulation of body fat to a sufficient magnitude 
to cause adverse consequences to health. A person with a body mass index (BMI) ≥ 30 
is generally considered obese. According to the World Health Organization (2014), 
more than a third of the world’s adult population (20 years old or above) was obese and 
overweight in 2008 (11 % was obese and the additional 24 % was overweight). 
Furthermore, obesity and overweight are also one of the leading risks for global deaths. 
Around 3.4 million adults are estimated to die each year due to the co-morbidities 
associated with obesity and overweight (World Health Organization, 2014). 
 
It has been widely known that obesity is reaching epidemic proportions in Western 
countries. For example, a recently published report revealed that more than one-third of 
U.S. adults (34.9 %) were obese by 2012 (Ogden, Carroll, Kit, & Flegal, 2014). In many 
Asian countries, the prevalence of overweight and obesity has increased many-fold over 
previous decades (Ramachandran & Snehalatha, 2010). Malaysia was ranked sixth and 
first for obesity in the Asia-Pacific region and South-East Asia, respectively (Edwards, 
2013). A national study in 2007 reported that the prevalence of obesity amongst adult 
Malaysians (18 years old or above) has markedly increased by 280 % since 1996 
(Rampal et al., 2007). This alarming rate of obesity has been attributed to high energy 
and fat consumption together with a low level of physical activity, and is associated 
with a significant risk for insulin resistance and type 2 diabetes mellitus, dyslipidemia, 
hypertension, cardiovascular disease, stroke, sleep apnea and certain forms of cancer 
(Khaodhiar et al., 1999). National strategies are urgently needed to prevent the 
escalation of obesity-induced morbidity.   
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2.2 Obesity, Inflammation and Insulin Resistance 
In recent years, much research efforts have been focused on delineating the association 
between obesity and insulin resistance. It has been suggested that inflammation 
contributes to the development of insulin resistance; the connection between the two 
conditions was established through a series of studies which observed the development 
of insulin resistance in diseases involving active inflammatory responses, such as sepsis, 
hepatitis C and human immunodeficiency virus infections, and rheumatoid arthritis 
(Bahtiyar, Shin, Aytaman, Sowers, & McFarlane, 2004; Clowes et al., 1978; Pao, Lee, 
& Grunfeld, 2008; Sidiropoulos, Karvounaris, & Boumpas, 2008). Interestingly, obese 
individuals are predisposed to developing insulin resistance, which is the primary defect 
leading to type 2 diabetes. Hotamisligil, Shargill, & Spiegelman (1993) discovered the 
first molecular link between obesity, inflammation and insulin resistance: increased 
level of tumor necrosis factor alpha (TNFα, a proinflammatory adipokine) mRNA and 
protein in adipose tissue of obese and/or diabetic mice compared to lean controls. Since 
then, accumulating literature have made it rapidly apparent that not only TNFα but an 
array of proinflammatory adipokines are elevated in obesity, leading to complications 
such as insulin resistance and diabetes mellitus (Berg & Scherer, 2005; Shoelson, Lee, 
& Goldfine, 2006).  
 
2.3 Roles of Adipose Tissue in Obesity-induced Inflammation 
Over the years, the biology of adipose tissue has been extensively studied in obesity-
related research because it is the predominant site sustaining stresses and inflammatory 
insults under obese conditions (Gregor & Hotamisligil, 2011). There are two types of 
adipose tissues: white adipose tissue (WAT) and brown adipose tissue (BAT). BAT 
serves as a fat depot for heat generation in neonates and young children during cold 
exposure (Lean, 1989). As an individual ages, BAT regresses by transforming into 
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WAT (Heaton, 1972). WAT is the physiological site of energy storage as lipids and 
contributes to the inflammation associated with obesity. Previously considered to be an 
inert, loose connective tissue for the storage of fats, investigators now appreciate that 
WAT is an active endocrine and paracrine organ, consisting of adipocytes 
predominantly, and the stromal vascular fraction of cells (including preadipocytes, 
fibroblasts, vascular endothelial cells and a variety of immune cells). Among these cell 
types, adipocytes and macrophages are able to secrete a wide array of adipokines 
(cytokines secreted by adipose tissue), such as TNFα, interleukin (IL) 6, IL1β and 
chemokine (C-C motif) ligand (CCL) 2, which promote inflammation and impair 
insulin sensitivity (Berg & Scherer, 2005; Shoelson et al., 2006). 
 
The anatomical distribution of WAT is strongly associated with co-morbidities of 
obesity. Many researchers have reported that intra-abdominal (visceral or omental) 
adipose tissue is more closely related to the co-morbidities of obesity than fat from the 
subcutaneous depot (Montague & O’Rahilly, 2000). The deleterious effect of omental 
fat is possibly due to its anatomical site with direct venous drainage to the liver, leading 
to full exposure of liver to undiluted repertoire of metabolites and secreted products by 
this fat depot (Montague & O’Rahilly, 2000). In addition, omental adipose tissue along 
with its resident macrophages is capable of producing more proinflamatory cytokines 
than the subcutaneous depot (Hamdy, Porramatikul, & Al-Ozairi, 2006).  
 
2.4 Hallmarks of Obesity-related Inflammation 
The inflammatory response in obesity is different from the classical inflammation, 
which is accompanied by the cardinal signs of redness, swelling, heat and pain 
(Hotamisligil, 2006). The classical response is often correlated with increased basal 
metabolic rate, resulting in a focused and rapid response by the immune system to the 
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site of infection or injury. Unlike the classical paradigm of inflammation, the obesity-
related inflammatory state is evoked by nutrient overload and associated with reduced 
metabolic rate. Notably, the inflammatory signals (adipokines and other mediators) 
from obese tissues are significant but often “low-grade” when compared to that of an 
infection, trauma or acute immune response (Gregor & Hotamisligil, 2011). In the 
condition of obesity (nutrient surplus), inflammatory signals originated from metabolic 
cells (such as adipocytes) create a modified milieu, leading to the recruitment and 
infiltration of immune cells into the tissue. Changes in the population of various 
immune cells, including macrophages, T cells, natural killer T cells and mast cells, have 
been reported in obese adipose tissues (Altintas et al., 2011; Ohmura et al., 2010; 
Weisberg et al., 2003; Yang et al., 2010). Inflammatory signals from both metabolic 
cells and infiltrating immune cells ultimately lead to an unresolved and chronic 
inflammatory response within the obese tissue, which can only be reversed or improved 
by weight loss (Cancello et al., 2005; Capel et al., 2009). 
 
2.5 Triggers to the Inflammatory Response Associated with Obesity 
 
2.5.1 Stress 
A key contributor to the metabolic inflammation of obesity is stress. In response to 
metabolic distress signals, the adipocyte is capable of engaging itself in inflammatory 
signaling events such as inflammasome and TLR activation, c-Jun N-terminal kinase 
(JNK) and nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) 
signaling, and production of inflammatory cytokines/adipokines, all of which are 
normally viewed as the territory of specialized immune cells (Gregor & Hotamisligil, 
2011).  
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During the development of obesity, adipocytes become hypertrophic, which 
subsequently leads to hypoxia because the oxygen availability does not match the 
demand of the surrounding tissue. The secretion and expression of a number of 
proinflammatory adipokines by adipocytes and local macrophages are upregulated in 
response to hypoxia, underpinning the occurrence of inflammation in adipose tissue 
during obesity (Wang, Wood, & Trayhurn, 2007; Ye, Gao, Yin, & He, 2007). 
Furthermore, hypoxia is known to inhibit macrophage migration from the affected 
region in tissues (Turner, Scotton, Negus, & Balkwill, 1999). An immunohistochemical 
study revealed the increased level of macrophage infiltration within hypoxic areas of 
obese adipose tissue (Rausch, Weisberg, Vardhana, & Tortoriello, 2008). Although the 
recruitment of macrophages may serve a beneficial role in removing dead and necrotic 
adipocytes (Cinti et al., 2005), macrophage activation inevitably causes the 
inflammation in obese adipose tissue (Weisberg et al., 2003). Remarkably, hypoxia is 
also able to induce ER stress in adipocytes (Hosogai et al., 2007). 
 
Obese adipose tissue displays an increased level of ER stress in comparison to the lean 
counterpart (Ozcan et al., 2004). To alleviate ER stress, unfolded protein response 
(UPR) is activated through three main transmembrane sensors that reside on the ER, 
namely PKR-like ER kinase (PERK), inositol-requiring enzyme 1 (IRE1) and activating 
transcription factor 6 (ATF6). By transmission of signals from the ER to the cytoplasm 
or nucleus through these factors, the UPR attempts to restore ER homeostasis by 
suppressing protein translation (Harding et al., 2000), increasing degradation of 
unfolded proteins (Travers et al., 2000), and increasing the level of chaperones to 
facilitate protein folding (Yoshida, Haze, Yanagi, Yura, & Mori, 1998). If these 
strategies fail, the UPR may also initiate apoptosis (Nakagawa et al., 2000). Prolonged 
activation of the UPR may trigger the production of reactive oxygen species (Santos, 
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Tanaka, Wosniak, & Laurindo, 2009), a process which is proinflammatory and 
apoptotic in nature. In vitro studies have demonstrated that free fatty acids (FFAs), 
which are elevated in obesity, are able to induce both ER and oxidative stresses in 
adipocytes (Furukawa et al., 2004; Jiao et al., 2011). FFA-induced ER and oxidative 
stresses have been shown to dysregulate the expression of IκB kinase β (IKKβ, a master 
kinase in regulating expression of inflammatory genes) and several proinflammatory 
adipokines, respectively.  
 
2.5.2 Nutrient  
There is evidence that inflammatory response may be induced, at least in part, by 
nutrients. For example, under normal conditions, the expression of STEAP family 
member 4 (STEAP4) increases in adipose tissue during feeding (Wellen et al., 2007). 
Gene knockout of STEAP4 in adipocytes and mice resulted in uncontrolled 
inflammatory response upon nutrient exposure, suggesting that STEAP4 may function 
as an immune suppressor in metabolic and immune cells in response to nutrient 
stimulation. Interestingly, the pattern of STEAP4 upregulation upon feeding disappears 
under the obese condition, correlating with increased inflammatory conditions 
commonly seen in obesity. Also, it has been shown that nutrient overload may induce 
pathogen sensors, leading to inflammation and insulin resistance. In adipocytes and 
macrophages, infusion of saturated fatty acids leads to the activation of TLR4 (Shi et 
al., 2006), which is the sensor for LPS. Moreover, negative effects of systemic lipid 
infusion and high-fat diet is partially negated by mice lacking TLR4, resulting in 
improved insulin sensitivity, possibly through reduced inflammatory gene expression in 
liver and fat (Shi et al., 2006).  
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2.5.3 Gut Microbiota 
Gut microbiota represents a new, promising area in the field of obesity research. The 
first important discovery in this area came from the observation of changes in the 
relative abundance of two dominant bacterial phyla, Bacteroidetes and Firmicutes, in 
the gut of obese animals (Ley et al., 2005). Interestingly, it has been shown that germ-
free animals are resistant to diet-induced obesity (Bäckhed, Manchester, Semenkovich, 
& Gordon, 2007). However, features of metabolic syndrome manifest in non-obese, 
germ-free mice after being inoculated with the gut microbiota from obese mice 
(Turnbaugh et al., 2006). Conversely, this phenomenon was not observed when the 
germ-free mice were colonized with intestinal microbiota of lean donor mice. Several 
mechanisms for the role of gut microbiota in obesity have been proposed, including the 
provision of extra energy by the bacterial conversion of dietary fiber to short-chain fatty 
acids and effects on the production of gut hormones (Blaut & Klaus, 2012). In addition, 
the release of bacterial LPS through the leaky gut constitutes one of the triggers to the 
low-grade inflammation in obesity. Specifically, a study showed that obese animals 
have an elevated population of Enterobacteriaceae (important producers of 
inflammatory LPS) in the gut, when compared to both low-fat-fed and obesity-resistant 
high-fat-fed animals (de La Serre et al., 2010). 
 
Insulin-resistant diet-induced and genetically obese mice as well as type 2 diabetic 
humans exhibit elevated circulatory LPS levels (Brun et al., 2007; Creely et al., 2007; 
Dasu, Devaraj, Park, & Jialal, 2010). It has been shown that circulatory LPS can trigger 
the adipose inflammation and systemic insulin resistance in humans, establishing the 
causal relationship between increased LPS level and impaired insulin sensitivity (Mehta 
et al., 2010). Interestingly, the increased level of serum LPS after feeding was reported 
in both mice and humans (Cani et al., 2007; Erridge, Attina, Spickett, & Webb, 2007). 
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This suggests that feeding increases the intestinal permeability to ensure maximum 
nutrient uptake, which in turn, paves the way for the release of inflammatory molecules 
from gut microbiota into the circulation. Incidentally, the intestine of obese animals is 
consistently more permeable than that of lean controls (Brun et al., 2007), 
corresponding to the increased level of circulatory LPS in obesity. 
 
2.6 Transcriptome Profiling in Obesity-related Studies 
The complex regulatory networks in adipose tissue are well-suited for an exploration 
with gene-expression (or transcriptome) profiling, which is an ideal tool for studying the 
molecular mechanisms of a polygenic disease like obesity. For instance, differential 
display reverse transcriptase-PCR (DDRT-PCR) had been employed to identify 
differentially expressed genes (DEGs) between subcutaneous and visceral adipose 
tissues from numerous animal models (Hishikawa et al., 2005). In 2007, Qiu et al. (2007) 
reported the use of another PCR-based method, suppression subtractive hybridization 
(SSH) to screen for dysregulated genes in omental adipose tissue of obese individuals. 
The most widely used instrument in gene-expression profiling over the last decade is the 
cDNA microarray. By comparing gene-expression profiles in adipose tissues from 
obese and non-obese subjects, many important insights into the pathogenesis of obesity 
and related diseases have been gained through microarray studies. For example, a 
microarray study on mouse adipose tissue revealed that the expression of adipogenic 
genes is decreased in obesity (Nadler et al., 2000). This provides one of the earliest 
indications that obese adipose tissue is associated with reduced adipogenesis and 
adipocyte hypertrophy, leading to complications such as ectopic lipid accumulation and 
insulin resistance. Nonetheless, the microarray technology has several inherent 
limitations, including dependence upon existing knowledge about genome sequences, 
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high background levels due to cross-hybridization and a limited dynamic range of 
detection owing to high background and saturation of signals (Wang et al., 2009). 
 
On the other hand, the sequencing-based technique is another useful tool for gene-
expression profiling. Bolduc et al. (2004) utilized the serial analysis of gene expression 
(SAGE) to examine the transcriptomic features of mouse adipose tissue. More recently, 
the advent of next-generation sequencing has dramatically changed the way that the 
functional complexity of transcriptomes can be studied. In particular, RNA-Seq can 
overcome the shortcomings of the microarray approach by being both sensitive and able 
to identify novel transcripts (Wang et al., 2009). Identification of candidate genes 
associated with obesity and nutrient stimulation has been reported in mice using the 
RNA-Seq approach (Zhang, Yao, Gao, & Abou-Samra, 2012; Zhang, 2012). To date, no 
RNA-Seq study that compares the mRNA profiles between obese and lean adipose 
tissues in humans has been reported (according to the PubMed database, using 
keywords: RNA-Seq, adipose tissue, obesity, and human, as of 23 November 2014). 
 
2.7 Differential Splicing in Obesity 
Alternative (or differential) splicing is a process which generates multiple transcripts 
from a single gene. This process increases the amount of protein isoforms, leading to 
changes in interactions of protein with other proteins, nucleic acids and membranes. The 
regulation of alternative splicing can be sequence-dependent. For instance, single-
nucleotide polymorphisms (SNPs) associated with obesity at multiple loci were found to 
be located near to sequences regulating alternative splicing (Goren et al., 2008), 
suggesting that alternative splicing may be a missing link between the SNPs and risks 
related to obesity. Alternatively, environmental factors can also influence the regulation 
of alternative splicing, as exemplified by a recent study which demonstrated that 
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alternative splicing can be controlled by circadian clock and feeding/fasting in mice 
(McGlincy et al., 2012). 
 
Several genes involved in adipogenic pathways have been found to be regulated by 
alternative splicing. Both peroxisome proliferator-activated receptor gamma (PPARγ) 
and delta-like 1 homolog (DLK1) are important regulators in the adipogenesis, with the 
former promoting and the latter inhibiting the process. Different protein isoforms of 
PPARγ and DLK1 were shown to have differential potential to activate and inhibit the 
adipogenic differentiation, respectively (Mei, Zhao, Chen, & Sul, 2002; Mueller et al., 
2002). Diazepam binding inhibitor (DBI), also known as Acyl-CoA binding protein 
(ACBP), has been speculated to play a role in lipogenesis (Hansen, Andreasen, 
Mandrup, Kristiansen, & Knudsen, 1991) and adipogenesis (Mandrup et al., 1998). It 
has been shown that the splicing pattern of DBI changes during the differentiation of 
human preadipocyte cell strain (Ludewig, Klapper, Wabitsch, Döring, & Nitz, 2011), 
suggesting the potential importance of its isoforms in fat cell differentiation. 
Transcription factor 7-like 2 (TCF7L2) is a transcription factor playing an important 
role in canonical Wnt signaling, whereby the activation of this pathway inhibits 
adipogenesis. Protein isoforms encoded by spliced variants of TCF7L2 exhibit 
differential ability to activate the Wnt signaling pathway (Weise et al., 2010). A recent 
study demonstrated that the short TCF7L2 mRNA variant in subcutaneous adipose 
tissue is regulated by weight loss and is associated with hyperglycemia and impaired 
insulin sensitivity in human adipose tissue (Kaminska et al., 2012). Further analysis 
showed that the total TCF7L2 expression remains unchanged, implying that the effect 
on RNA splicing is independent of regulation of transcription. 
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CHAPTER 3: METHODOLOGY 
 
Figure 3.1 summarizes the workflow of the current study. 
 
 
Figure 3.1: The workflow of this study. Abbreviation: DAVID for Database for 
Annotation Visualization and Integrated Discovery; FunDO for Functional Disease 
Ontology; TV for transcript variant 
 
3.1 Sampling 
Potential candidates were recruited from the patients who underwent laparoscopic 
abdominal surgery at the University of Malaya Medical Center (UMMC) between 
October 2012 and September 2013. Patients were excluded if they were suffering from 
diabetes mellitus, active infection or cancer and if they were either below 18 or above 
60 years old. The BMI (weight [kg] divided by square of height [m]) was used to 
classify patients as obese or lean. Obesity was defined as BMI ≥ 30 kg/m2, while 
leanness was BMI < 26 kg/m2. A total of 18 patients (eight obese and 10 lean) were 
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recruited into the study. Their clinical characteristics are given in Table 3.1. The 
sampling protocol of this study was approved by the Medical Ethics Committee of the 
UMMC (reference number: 896.24). Written informed consent (Appendix A) was 
obtained from all patients, following a detailed explanation of the nature of the study. 
 
Table 3.1: Clinical data of obese and lean patients 
Analysis Feature Obese Lean p-value 
RNA-Seq n (male, female) 2, 1 1, 3   
  Age 39 ± 9 46 ± 4 NS 
  Weight (kg) 105.0 ± 13.7 58.4 ± 2.7 * 
  Height (m) 1.61 ± 0.03 1.59 ± 0.04 NS 
  BMI (kg/m2) 40.2 ± 4.8 23.0 ± 0.6 * 
  Glucose (mmol/l) 5.5 ± 0.6 5.0 ± 0.4 NS 
  Triglyceride (mmol/l) 1.3 ± 0.2 1.4 ± 0.3 NS 
  Total cholesterol (mmol/l) 5.7 ± 1.2 5.3 ± 0.2 NS 
  HDL (mmol/l) 1.3 ± 0.4 1.6 ± 0.2 NS 
  LDL (mmol/l) 3.8 ± 0.9 3.1 ± 0.4 NS 
RT-qPCR n (male, female) 2, 3 4, 2   
  Age 46 ± 6 36 ± 7 NS 
  Weight (kg) 107.0 ± 21.4 57.9 ± 4.1 * 
  Height (m) 1.60 ± 0.06 1.63 ± 0.04 NS 
  BMI (kg/m2) 40.4 ± 5.6 21.8 ± 1.3 * 
  Glucose (mmol/l) 5.4 ± 0.1 4.8 ± 0.3 NS 
  Triglyceride (mmol/l) 1.8 ± 0.1 1.7 ± 0.4 NS 
  Total cholesterol (mmol/l) 5.3 ± 0.5 4.9 ± 0.3 NS 
  HDL (mmol/l) 1.1  ± 0.1 1.2  ± 0.1 NS 
  LDL (mmol/l) 3.4 ± 0.4 2.9 ± 0.2 NS 
 
Data are presented in mean ± standard error. Difference in mean between the obese and 
lean groups was analyzed using the two-sample t-test. Abbreviation: NS for not 
statistically significant; * for p-value < 0.05 
 
3.2 RNA Preparation 
During the laparoscopic surgery, the specimen of omental adipose tissue was excised 
under direct camera vision from the greater omentum by an experienced surgeon. The 
fat was then extracted through the sleeve of the 12-mm laparoscopic port without any 
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direct contact with the subcutaneous fat. Immediately, the tissue was cut and placed in 
Allprotect Tissue Reagent (Qiagen). With 0.1-0.15 g of stabilized adipose tissue as 
starting material, RNA purification was performed using RNeasy Lipid Tissue Mini Kit 
(Qiagen). To ensure the complete removal of contaminating DNA, on-column DNase 
digestion was carried out with RNase-free DNase (Qiagen). Quality inspection of each 
RNA sample was performed using the 2100 Bioanalyzer RNA 6000 Nano Assay 
(Agilent) and Nanodrop 2000 (Thermo Scientific). Only the first seven RNA samples 
(three obese and four lean, Table 3.1) that passed the quality inspection (amount > 1 µg  
and RNA Integrity Number > 7) were further processed for RNA-Seq (Appendix B).  
 
3.3 Library Preparation and RNA-Seq 
The SureSelect Strand-specific RNA Library Prep Kit (Agilent) was used for the RNA-
Seq library preparation. Briefly, 1 µg of total RNA was used for poly(A) RNA 
enrichment using oligo(dT) magnetic particles, followed by a chemical fragmentation of 
mRNA. The fragmented mRNA was then subjected to first-strand cDNA synthesis and 
second-strand cDNA synthesis with dUTP. This was followed by end repair, ligation of 
adaptors and finally, 14 cycles of PCR amplification with indexing primers and uracil-
DNA glycosylase. The size distribution of the purified library was assessed with the 
2100 Bioanalyzer DNA 1000 Assay (Agilent); a good library should have an expected 
size range of 200 to 600 bp and should not contain adaptor-dimers at the region of 100 
to 150 bp. The libraries were sequenced by Ambry Genetics (USA). At a concentration 
of 6 pM each, seven indexed libraries were pooled and sequenced on three Illumina 
HiSeq 2000 lanes using 2 × 100 bp sequencing protocol.  
 
With data generated from the sequencer, raw reads were mapped to a reference genome, 
National Center for Biotechnology information (NCBI) Build 37.2 
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(http://tophat.cbcb.umd.edu/igenomes.shtml) using Tophat2 version 2.0.4 (Kim et al., 
2013). A GTF file containing the transcript location was downloaded from the Tohpat2 
webpage and used to guide the Tophat2 mapper. The first run of Tophat2 was invoked 
with a –G option to build a transcriptome index using the GTF file. Transcriptome index 
from the first run was used to guide the Tophat2 mapper (with option –
transcriptome-index) for the processing of subsequent samples. Tophat2 was 
invoked with two other option changes: –b2-very-sensitive, which maximizes 
the number of mappable reads and is equivalent to the –very-sensitive option for 
Bowtie2 (http://bowtie-bio.sourceforge.net/bowtie2/index.shtml); –fr-
firststrand, which assumes that only the strand generated during first strand 
synthesis is sequenced, as assumed in the SureSelect Strand-specific RNA Library Prep 
Kit (Agilent). Other than that, all other Tophat2 options followed the default settings. 
The raw and processed data were deposited in Gene Expression Omnibus (GEO) under 
accession number: GSE55008.  
 
3.4 Genespring Analysis 
The BAM files generated from Tophat2 were imported into Genespring version 12.5 
(Agilent, Appendix C) for further analysis. Prior to the differential expression and 
splicing analyses, the read data were filtered for duplicate reads (generated from PCR 
bias during the library preparation), average Phred score below 30 and nucleotide 
ambiguity above 0 %. Read count normalization was then carried out using DESeq 
(Anders & Huber, 2010). 
  
Prior to performing differential expression analysis, genes with low-read coverage per 
condition (less than 50 raw reads in all samples in either one of the two phenotype 
classes) were filtered. The moderated t-test (Smyth, 2004) was performed for each gene 
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and only those genes with p-value < 0.05 were classified as DEGs. Because of the small 
sample size of the study, p-value adjustments that are usually done in multiple testing 
situations were not feasible, as very few or no genes at all could attain statistical 
significance at the nominal 5 % level. DEGs with fold change (FC) ≥ 2 were used for 
further functional analyses.  
 
Differential splicing analysis was performed using the gene list generated after the 
removal of genes with low-read coverage per condition. To account for isoform read-
mapping uncertainty, Genespring collects reads that cannot be mapped to any of the 
existing isoforms into a class called “unknown isoform”, and estimation of the number 
of reads mapped to the isoform of interest under read-mapping uncertainty was done 
using the method of Li, Ruotti, Stewart, Thomson, and Dewey (2010). Isoform 
proportion was calculated by dividing the estimated reads mapped to each isoform with 
the total number of reads mapped to all isoforms of a gene. If the difference in 
proportion of the isoform (i.e. the splicing index, SI), was greater than 0.25 or less than 
-0.25 between the obese and lean groups, the gene was declared to be differentially 
spliced. The Mann-Whitney U test was used to determine whether the obese and lean 
groups differed significantly in their median proportions. The p-value of 0.1 was used as 
a cutoff for statistical significance because non-parametric methods are less powerful 
when the sample size is small (the smallest p-value attainable with n = 7 using the 
Mann-Whitney U test is 0.06).  
 
3.5 Functional Enrichment Analyses 
The Database for Annotation Visualization and Integrated Discovery (DAVID) version 
6.7 (http://david.abcc.ncifcrf.gov/) was used to study biological functions enriched in 
the candidate DEGs of obesity (Dennis et al., 2003; Huang, Sherman, & Lempicki, 
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2009). The Functional Disease Ontology (FunDO) analysis 
(http://fundo.nubic.northwestern.edu/) was also performed on the candidate DEGs to 
investigate the association between disease and gene-expression changes, based on 
Disease Ontology and peer-reviewed evidence from GeneRIF (Osborne et al., 2009). 
 
3.6 RT-qPCR 
With 11 independent samples (five obese and six lean patients, Table 3.1), real-time 
quantitative reverse transcription PCR (RT-qPCR) was performed to validate the lead 
from differential splicing analysis of TLR4. Briefly, cDNA was synthesized from 300 ng 
of RNA using the High Capacity RNA-to-cDNA kit (Life Technologies). Each cDNA 
sample was diluted 1:10 for subsequent PCR analysis. The mRNA levels of TLR4 
transcript variants (TVs): TV1 and TV3, were measured in triplicate using the Rotor-
Gene Q real-time PCR cycler (Qiagen) with inventoried Taqman Gene Expression 
assays (Life Technologies). For every patient, the expression of target TV was 
calculated using the formula: expression = 1/(efficiency + 1)Cq. Then, the ratio of TV3 
to TV1 expression of each patient was computed. Reference genes were not included in 
this study because relative quantification was not performed. The Minimum Information 
for Publication of Quantitative Real-Time PCR Experiments (MIQE) checklist (Bustin 
et al., 2009) for this study is given in Appendices D1 and D2. 
  
3.7 Correlation Analysis 
Using R version 2.15.2 (R Core Team, 2012) and the ppcor package (Kim & Yi, 
2007), the association between TV3/TV1 ratio (obtained from RNA-Seq and RT-qPCR) 
and BMI was investigated. The partial Spearman correlation was used to control for the 
effects of gender and age. Data used in the partial correlation analysis are presented in 
Appendix E. 
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CHAPTER 4: RESULTS 
 
4.1 Pre-analysis Data Processing 
The total number of reads generated for each adipose tissue biopsy ranged from 24 to 41 
million, with a median of 36.2 million and a mean of 35.4 ± 6 million (standard 
deviation). According to the key metrics extracted from Tophat2, 90.8 to 93.5 % of 
reads were aligned to the reference genome. For pre-analysis filtering using Genespring, 
between 18.2 to 29.6 % of duplicate reads and 1.8 to 1.9 % of reads with ambiguous 
nucleotide or low quality score (Phred score < 30) were removed. 
 
4.2 Differential Expression Analysis 
One thousand one hundred and one genes with significant difference (p-value < 0.05) in 
their expression between obese and lean adipose tissues were identified. Among these, 
206 are differentially expressed by at least two-fold in the obese group. The overall 
gene-expression changes (expressed in FC) are between 23-fold downregulated and 15-
fold upregulated (reference: lean group). Among the 206 DEGs with FC ≥ 2, the 
changes in their expression are skewed towards upregulation in the obese group (141 up 
and 65 down). The top 10 up- and down-regulated genes detected in obese adipose 
tissue are listed in Table 4.1.  
 
Most of the microarray-based studies published to date used subcutaneous adipose 
tissue or cultured adipocytes or preadipocytes, which have important differences from 
omental adipose tissue of obese patients (Montague & O’Rahilly, 2000; Soukas, Socci, 
Saatkamp, Novelli, & Friedman, 2001). Since omental adipose tissues were used in this 
study, a direct comparison cannot be made between findings from this study and those 
from most previous microarray studies. Nonetheless, some concordances were observed 
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between gene-expression differences found with this RNA-Seq study and the few 
microarray studies published using omental adipose tissue. For example, in the present 
RNA-Seq and previous microarray studies, leptin (LEP), secreted phosphoprotein 1 
(SPP1), tenomodulin (TNMD), and complement component 1, q subcomponent, A chain 
(C1QA) are upregulated in obese omental adipose tissue while complement component 6 
(C6) and cysteine-rich, angiogenic inducer, 61 (CYR61) are consistently downregulated 
(Baranova et al., 2005; del Pozo et al., 2011; Gómez-Ambrosi et al., 2004). In contrast, 
several genes identified in this study show a pattern of differential gene expression 
which is contradictory to previous microarray studies (Table 4.2).  
 
A number of DEGs identified in this study have not been previously reported to be 
associated with obesity. For instance, NFAM1 and FPR3, which encode for NFAT 
activating protein with ITAM motif 1 and formyl peptide receptor 3 respectively, might 
be functionally relevant to obesity because of their roles in leukocyte signaling and 
development.  
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Table 4.1: Top 10 up- and down-regulated genes in obese adipose tissue 
Entrez 
ID 
Gene 
Symbol 
Description p-value FC Lean group* Obese group* 
6696 SPP1 Secreted 
phosphoprotein 1 
7 × 10-3 14.9 96.3 ± 39.6 1436.2 ± 2656.2 
64102 TNMD Tenomodulin 1 × 10-2 9.6 138.4 ± 124.0 1323.1 ± 1226.7 
84966 IGSF21 Immunoglobin 
superfamily, member 
21 
3 × 10-3 6.4 10.2 ± 5.9 65.1 ± 19.5 
6362 CCL18 Chemokine (C-C 
motif) ligand 18 
(pulmonary and 
activation-regulated) 
2 × 10-2 6.1 36.3 ± 59.0 221.1 ± 49.5 
3223 HOXC6 Homeobox C6 1 × 10-2 5.5 41.2 ± 16.2 225.8 ± 165.2 
9242 MSC Musculin 5 × 10-2 5.2 51.6 ± 34.7 268.2 ± 343.6 
158800 RHOXF1 Rhox homeobox 
family, member 1 
8 × 10-3 5.1 14.2 ± 6.6 71.9 ± 49.9 
377007 KLHL30 Kelch-like family 
member 30 
4 × 10-2 5.0 41.6 ± 36.9 209.4 ± 164.4 
340443 RPS5P5 Ribosomal protein S5 
pseudogene 5 
4 × 10-2 5.0 49.3 ± 50.1 247.3 ± 195.7 
3952 LEP Leptin 5 × 10-3 4.9 4031.8 ± 1714.4 19755.5 ± 9888.5 
761 CA3 Carbonic anhydrase 
III, muscle specific 
3 × 10-3 -23.0 2837.8 ± 2554.7 123.5 ± 80.8 
579 NKX3-2 NK3 homeobox 2 9 × 10-3 -14.7 111.6 ± 19.7 7.6 ± 13.8 
80763 C12orf39 Chromosome 12 open 
reading frame 39 
2 × 10-2 -13.2 512.3 ± 620.8 38.9 ± 15.5 
6096 RORB RAR-related orphan 
receptor B 
5 × 10-3 -11.1 303.0 ± 179.3 27.3 ± 22.1 
7138 TNNT1 Troponin T type 1 
(skeletal, slow) 
5 × 10-2 -10.2 238.2 ± 238.5 23.3 ± 54.4 
84675 TRIM55 Tripartite motif 
containing 55 
1 × 10-2 -6.5 138.1 ± 133.6 21.2 ± 4.1 
3491 CYR61 Cysteine-rich, 
angiogenic inducer, 
61 
4 × 10-2 -5.6 3726.5 ± 4551.1 660.5 ± 46.2 
5744 PTHLH Parathyroid hormone-
like hormone 
3 × 10-2 -4.7 152.3 ± 36.7 32.7 ± 31.9 
8913 CACNA1G Calcium channel, 
voltage-dependent, T 
type, alpha 1G 
subunit 
3 × 10-2 -4.5 128.6 ± 67.3 28.8 ± 29.1 
125336 LOXHD1 Lipoxygenase 
homology domains 1 
2 × 10-2 -4.2 328.7 ± 266.4 78.0 ± 8.3 
 
* Normalized read count data are presented in mean ± standard deviation 
 
  
23 
 
Table 4.2: Discordant findings of differential gene expression between studies using the 
RNA-Seq (current study) and the microarray approach 
Gene 
symbol 
Description RNA-
Seq 
Micro-
array 
Reference 
NPR3 Natriuretic peptide 
receptor C/guanylate 
cyclase C  
Up Down Gómez-Ambrosi et al., 2004 
CDKN2B Cyclin-dependent kinase 
inhibitor 2B 
Up Down Gómez-Ambrosi et al., 2004 
DNER Delta/notch-like EGF 
repeat containing 
Down Up Baranova et al., 2005 
ADRB1 Adrenoceptor beta 1 Up Down Baranova et al., 2005 
 
4.3 FunDO Analysis 
To check the veracity of the RNA-Seq analysis, candidate DEGs were categorized into 
different disease ontology (DO) terms using FunDO. Five disease nodes are evident 
(Figure 4.1A), with the size of each node proportional to the number of its constituent 
genes. As expected, obesity (corrected-p value = 10-6) is the most over-represented DO 
term (Figure 4.1B), supporting the validity of the sample inclusion criteria and 
bioinformatic approach of this study in the biological context. Diabetes mellitus 
(corrected p-value = 2 × 10-5), which has 12 hit genes and shares five of them (SPP1, 
integrin beta 2 [ITGB2], hydroxysteroid (11-beta) dehydrogenase 1 [HSD11B1], 
TNMD, and ISL LIM homeobox 1 [ISL1]) with obesity, is ranked second. This 
highlights the close link between the pathophysiology of the two diseases. Despite being 
statistically significant, the enrichment of biliary atresia (rank 3), enteritis (rank 4) and 
heart failure (rank 5) might not be biologically meaningful, as demonstrated by their 
relatively small disease nodes in comparison to those of obesity and diabetes mellitus.  
 
24 
 
 
Figure 4.1: Correlations between candidate differentially expressed genes and the top 
five diseases identified by FunDO. (A) The map of the top five diseases over-
represented with the genes showing dysregulated expression in diseased adipose tissue. 
(B) The number of hit genes and Bonferroni-corrected p-values of the top five enriched 
DO terms. 
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4.4 DAVID Analysis 
The basis of enrichment analysis is that if a biological process is unusual in a given 
study, the co-functioning genes should be more likely (enriched) to be picked up as a 
relevant group by the high-throughput screening technologies. In this study, 13 clusters 
(Appendix F) were identified with enrichment scores passing the cutoff threshold of 1.3, 
which corresponds to a p-value of 0.05 (Huang et al., 2009). Only functions that are 
significantly enriched, defined as satisfying p-value < 0.05 and false discovery rate 
(FDR) at 10 %, are reported here. In general, the result suggests that the dysregulated 
genes in omental adipose tissue of obese patients are involved in multiple functions 
including cell adhesion, response to stress, inflammatory response, chemotaxis, 
leukocyte adhesion, insulin-like growth factor (IGF) binding, and regulation of 
adenylate cyclase activity.  
 
Augmented leukocyte infiltration is well-documented in diseased adipose tissue of 
obesity (Altintas et al., 2011; Weisberg et al., 2003; Yang et al., 2010). In line with this 
observation, cell adhesion (cluster 1), chemotaxis (cluster 3) and leukocyte adhesion 
(cluster 10) were enriched in the candidate DEGs in obesity. A significant portion of 
genes mapped to these functions, including members of the integrin (transmembrane 
receptors) family (ITGB2 and integrin alpha M [ITGAM]) are upregulated in obesity. 
Several genes enriched in the cell adhesion function, namely neural cell adhesion 
molecule 2 (NCAM2), roundabout, axon guidance receptor, homolog 2 (Drosophila) 
(ROBO2), protocadherin beta 7 (PCDHB7), and SCO-spondin homolog (Bos taurus) 
(SSPO), are also associated with neural development; some of the genes involved in 
neural development have previously been implicated in the adipogenic differentiation 
(Billon et al., 2010; Yang et al., 2011). 
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The most over- and under-expressed genes, SPP1 and carbonic anhydrase III (CA3), are 
mapped to the response to stress cluster (cluster 2). The majority of genes involved in 
the inflammatory response (cluster 2), which includes those encoding members of 
complement systems (C1QA, complement component 1, q subcomponent, B chain 
[C1QB], complement component 1, q subcomponent, C chain [C1QC], and complement 
component 3a receptor 1 [C3AR1]) and inflammatory cytokines (CCL18 and SPP1), is 
overexpressed in obese adipose tissue. This signifies the positive regulation of immune 
response in obesity. Interestingly, both inflammatory response and response to stress are 
organized in the same cluster, whereby all the genes mapped to the former are also 
involved in the latter function. This reflects the frequent occurrence of stress-induced 
inflammation in obese adipose tissue.  
 
Genes participating in IGF binding (cluster 7) are dysregulated in obese adipose tissue; 
these include those encoding members of IGF binding proteins (insulin-like growth 
factor binding protein 6 [IGFBP6]) and Connective tissue growth factor, Cystein rich 
protein, and Nephroblastoma overexpressed gene (CCN) family proteins 
(CYR61/CCN1, CTGF/CCN2 and WISP2/CCN5) that have been reported to be involved 
in the process of adipogenesis (Ng et al., 2008; Schutze, Noth, Schneidereit, Hendrich, 
& Jakob, 2005). While the downregulation of CYR61 and connective tissue growth 
factor (CTGF) is in line with the promotion of adipogenesis, the upregulation of WNT1 
inducible signaling pathway protein 2 (WISP2) and downregulation of IGFBP6 implies 
impairment of adipogenesis in obese adipose tissue; the impairment of adipogenesis has 
been shown to mediate adipocyte hypertrophy and ectopic lipid accumulation in obesity 
(Gustafson et al., 2009). 
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A number of candidate DEGs are enriched in the regulation of adenylate cyclase 
activity (cluster 13) that has been linked to the lipolytic defects in obese adipose tissue 
(Martin et al., 1990). The genes for both adrenoceptor alpha 2A (ADRA2A) and 
adrenoceptor beta 1 (ADRB1) are upregulated in obese adipose tissue. It has been 
reported that ADRB1 promotes while ADRA2A inhibits lipolysis in adipose tissue 
through the promotion and inhibition of cyclic adenosine monophosphate (cAMP) 
formation in catecholamine signaling (Alfredo Martínez et al., 2007; Stich et al., 2000). 
The paradoxical upregulation of ADRB1 seems to contradict the idea of diminished 
lipolysis in obesity. 
 
4.5 Differential Splicing Analysis 
Forty-nine differentially spliced genes (DSGs) were found in obesity (p-value < 0.1, 
absolute SI > 0.25, Appendix G). DAVID functional annotation chart was used to 
identify enriched functions in these 49 DSGs; the top enriched function is immune 
response-activating signal transduction (p-value < 0.01, FDR = 13 %). One of the DSGs 
mapped to this function, TLR4, is of particular interest because of its widely reported 
relevance to obesity-associated inflammation (Ahmad et al., 2012; Kim, Gu, Lee, Joh, 
& Kim, 2012; Shi et al., 2006). In addition, TLR4 was chosen because functions of its 
protein isoforms, generated through alternative splicing, have been described (Coats, 
Pham, Bainbridge, Reife, & Darveau, 2005); these information were used to facilitate 
the biological interpretation of the RNA-Seq data. 
 
Using the Genome Browser in Genespring, a difference in expression level for the 
individual exons in TLR4 was noticed (Figure 4.2A); the low level of reads that mapped 
to the intron regions are probably derived from pre-mRNA. According to the Refseq 
annotation, all three TVs, TV1 (NM_138554), TV3 (NM_003266), TV4 (NM_138557) 
share Exon I and IV but the additional exon II is present exclusively in TV3. The 
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proportion of TV3 in TLR4 expression (TV3/sum of all TVs of TLR4) is decreased 
significantly in obesity (SI = -0.29, p-value = 0.06) (Figure 4.2B). Interestingly, the 
proportion of the canonical isoform TV1 is significantly higher in obese adipose tissue 
(p-value = 0.06), with SI marginally below the specified threshold (SI = 0.21). TV4 is 
generally expressed in very low abundance compared to the other two isoforms and the 
difference in its proportion between obese and lean adipose tissues is not statistically 
significant (p-value = 0.22). Hence, TV4 was excluded from further analysis. The 
percentage of the unknown isoform is 5.0 ± 2.8 % (1 standard deviation). 
 
 
Figure 4.2: Differential splicing of TLR4 transcript. (A) Reads mapped to the reference 
(Refseq annotation) for TLR4. (B) Proportion of isoforms in TLR4 expression across 
obese and lean conditions. Data are expressed in mean ± standard error. Abbreviation: * 
for p-value = 0.06 
 
Both isoforms under investigation have been reported to play antagonistic roles in TLR4 
signaling, with TV3 attenuating while TV1 promoting the signaling pathway (Coats et 
al., 2005). To quantify the degree of inhibition/activation of TLR4 signaling, the ratio of 
TV3 to TV1 expression of each patient was computed. Using partial Spearman 
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correlation analysis, a strong negative association between TV3/TV1 ratio and BMI was 
detected (r = -0.81, p-value = 0.02; Figure 4.3A). RT-qPCR analysis with an 
independent, larger cohort of samples (five obese and six lean) further supports this 
finding (r = -0.82, p-value = 0.0002; Figure 4.3B).  
 
 
Figure 4.3: Association of TV3/TV1 ratio with BMI using data generated from (A) 
RNA-Seq (n = 7) and (B) RT-qPCR (n = 11). Abbreviation: m for male; f for female 
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CHAPTER 5: DISCUSSION 
 
5.1 Discrepancy between Results Generated from RNA-Seq and Microarray 
Approaches  
Many of the gene-expression changes observed between obese and lean omental 
adipose tissues in the current study are similar to those reported previously in 
microarray studies. Nonetheless, some discrepancies were also observed. For example, 
the upregulation of NPR3 in this study is contradictory to the previous findings by 
Gómez-Ambrosi et al. (2004). A potential cause of the discrepancy between RNA-Seq 
data from this study and previously reported transcriptome profiles is the intrinsic 
limitation of microarray technology, such as high background noise of hybridization 
that limits the precision of microarray expression measurements (Wang et al., 2009). 
Interestingly, a transcriptomic analysis of mouse adipose tissues by microarray did 
demonstrate the overexpression of NPR3 gene in obesity (Morton et al., 2011), as 
observed in the current study. In that study, the authors discussed the possible outcome 
from the upregulation of NPR3 in obesity; NPR3 encodes the signaling-deficient 
natriuretic peptide receptor C that functions mainly as a clearance receptor by 
sequestering atrial natriuretic peptide (a lipolytic ligand). Therefore, the upregulation of 
NPR3 is likely to contribute to obesity by abrogating the lipolytic effect of atrial 
natriuretic peptide. 
 
5.2 Enrichment Analysis Highlights the Likelihood of Stress-induced 
Inflammation in Obese Adipose Tissue 
Obesity is associated with elevated stress level in adipose tissue (Bondia-Pons et al., 
2012; Cnop et al., 2012; Trayhurn, 2013). In line with that finding, the DEGs identified 
in obesity are enriched in response to stress. In particular, the most up- and down-
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regulated genes in obese adipose tissue, SPP1 and CA3 respectively, are among the 
DEGs mapped to this function. The product encoded by SPP1 (secreted phosphoprotein 
1 or more commonly known as osteopontin) is a multifunctional adipokine, known to 
regulate processes like adipogenesis and inflammation in obesity (Zeyda et al., 2011). A 
gene knockout study suggests that SPP1 is also a promoter of oxidative stress (Irita et 
al., 2011). In addition, increased secretion of this protein has been observed in dendritic 
cells cultured under hypoxic conditions (Yang et al., 2009). Thus, the upregulation of 
SPP1 reflects the hypoxic, oxidative and pro-inflammatory microenvironment in 
adipose tissue of obese humans. On the other hand, CA3 is one of the most abundant 
transcripts found in human (Gabrielsson, Carlsson, & Carlsson, 2000) and rodent 
(Bolduc et al., 2004) adipose tissues and has been speculated to play a role in the 
protection against reactive oxygen species generated in the metabolically active fat 
tissues (Räisänen et al., 1999). The overwhelming downregulation of CA3 observed in 
this study is consistent with the finding of obesity-associated downregulation of CA3 in 
adipose tissue of genetic/diet-induced models of obesity (Stanton, Ponte, Coleman, & 
Snyder, 1991). Underexpression of CA3 implies the inability of obese adipose tissue to 
neutralize oxidative stress. 
 
It has been suggested that stress is a trigger of immune dysregulation seen in obese 
adipose tissue (Bondia-Pons et al., 2012; Cnop et al., 2012; Trayhurn, 2013). In this 
study, the enrichment analysis supports this hypothesis as all 13 DEGs mapped to the 
inflammatory response are found to be involved in response to stress. Of these 13 
DEGs, C1QA, C1QB, C1QC and C6 are found to be enriched in complement activation, 
classical pathway (cluster 2). Interestingly, oxidative stress has been reported to initiate 
complement activation and result in immune dysregulation and organ injury (Collard, 
Lekowski, Jordan, Agah, & Stahl, 1999). Except for C6, all members of the classical 
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complement pathway are upregulated in obese patients. Although the underexpression 
of C6 has been described in obese adipose tissue (del Pozo et al., 2011), its association 
with oxidative stress, complement activation and inflammatory response in obesity 
remains a subject for further investigation. Furthermore, CD14 molecule (CD14), an 
important member of TLR4 signaling, was detected to be upregulated in obesity. A 
recent study by Coope et al. (2012) has shown that CD14 plays an important role in 
mediating unfolded protein response induced by LPS. The changes observed in CD14 
expression and TLR4 splicing pattern in this study are relevant to inflammatory and ER 
stress responses observed in obesity (Coope et al., 2012; Pierre et al., 2013). 
 
Genes involved in processes of chemotaxis and leukocyte adhesion are also 
significantly represented, which is consistent with the finding that obese adipose tissue 
is associated with augmented leukocyte infiltration. Upregulated genes included in these 
groups are those encoding for ITGB2, ITGAM, CCL18, FPR3, C3AR1, CD209, spleen 
tyrosine kinase (SYK), and platelet-activating factor receptor (PTAFR). Collectively, 
the upregulation of these genes in obese adipose tissue may enhance the 
chemotactic/adhesive activity of a wide array of immune cells, including but not limited 
to monocytes/macrophages, T cells, and neutrophils (information retrieved from Gene 
Ontology, Refseq, and Uniprot).  
 
As for IGF binding and adenylate cyclase activity, the activity of these functions 
(increase or decrease) could not be predicted based on the differential expression 
patterns (up- or down-regulation) of enriched genes. Further studies will be needed to 
demonstrate conclusively that these functions are indeed associated with obesity in the 
Malaysian population. 
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5.3 Differential Splicing Analysis Uncovers the Potential Involvement of TLR4 
Transcript Variants in Obesity-related Inflammation of Adipose Tissue 
Evidence from animal studies suggests that translocation of bacterial LPS across the gut 
may initiate obesity-associated low-grade inflammation (Cani et al., 2007). This unusual 
phenomenon has also been reported in obese and diabetic humans (Hawkesworth et al., 
2013). TLR4 plays an important role in innate immunity because it detects LPS from 
Gram-negative bacteria, which leads to the production of pro-inflammatory cytokines. 
Indeed, it has been shown that LPS can induce adipose inflammation and insulin 
resistance in humans (Mehta et al., 2010). Therefore, changes in TLR4 signaling are 
highly relevant in obesity and its co-morbidities. 
 
TLR4 signaling is tightly regulated to prevent over-activation of immune response 
(Gray et al., 2010). One of the mechanisms to downregulate TLR4 signaling involves 
the synthesis of inhibitory isoforms through alternative splicing (Iwami et al., 2000; 
Jaresová et al., 2007). Alteration of the kinetics of TLR4 splice variants expression has 
been reported to be associated with diseases like cystic fibrosis (Jaresová et al., 2007). 
Differential splicing of TLR4 has not been reported previously in the disease-state 
adipose tissue in obesity. 
 
TLR4 has three transcript isoforms. TV1 encodes protein isoform A, the canonical 
TLR4 bearing an N-terminal signal sequence which is absent in isoforms C and D, 
encoded by TV3 and TV4, respectively (Coats et al., 2005). In the present study, a 
significant decrease in TV3 proportion was observed in the obese group as compared to 
their lean counterparts. There are two hypotheses describing the function of this isoform 
of TLR4. According to Iwami et al. (2000), human TLR4 exon II (which is specific to 
TV3) has an in-frame stop codon, which might give rise to a small protein isoform 
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without transmembrane and intracellular domains, analogous with the soluble mouse 
TLR4 protein (smTLR4); they have shown that smTLR4 is able to attenuate LPS-
induced TLR4 signaling. On the other hand, Coats et al. (2005) found that the absence 
of the signal sequence at the N terminus renders the isoform C non-functional as it fails 
to associate with LY96, whereby this association confers responsiveness to LPS. In 
addition, through molecular cloning and transformation, they also demonstrated that 
only the protein encoded by TV1, but not by TV3 or TV4, illicits NF-κB activity in 
response to LPS in the HEK293 cell line. Both hypotheses support the inhibitory role of 
TV3 in TLR4 signaling. The altered kinetics in the alternative splicing of TLR4 gene, as 
observed in the decrease in inhibitory TV3 and the increase in canonical TV1 
proportion, signifies the up-regulation of TLR4 signaling in obesity.  
 
To quantify these changes observed in obesity in a biologically meaningful way, the 
ratio of TV3 to TV1 expression was calculated and correlated with the BMI. There is a 
significant association between the TV3/TV1 ratio and BMI of the patients (r = -0.81, p-
value = 0.02). Partial correlation was used to adjust for the effects of gender and age 
because TLR4 signaling can be affected by sex difference and aging (Renshaw et al., 
2002; Roberts, Moussawi, & Huber, 2013). Collectively, these findings indicate that, as 
a person experiences weight gain or obesity, the kinetics of adipose splicing pattern for 
TLR4 changes in favor of higher activation and lowering inhibition of TLR4 signaling. 
Further experimental validation using methods like protein immunoassay and RNA 
silencing is necessary for pursuing this line of thought. 
 
To uncover more supporting evidence for the upregulation of TLR4 signaling in 
obesity, a pathway analysis in Genespring was performed (Appendix H). By mapping 
1101 genes that are significantly different in expression level between obese and lean 
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groups (p-value < 0.05) to TLR signaling pathway 
(http://www.wikipathways.org/index.php/Pathway:WP75), five genes, namely mitogen-
activated protein kinase 3 (MAPK3), Fas (TNFRSF6)-associated via death domain 
(FADD), lymphocyte Antigen 96 (LY96), mitogen-activated protein kinase kinase 1 
(MAP2K1), and CD14 (in ascending order of their respective FC; as indicated by 
asterisks in Appendix H), were identified to be involved in the TLR4 signaling pathway. 
Notably, LY96 and CD14 are important members of this signaling pathway, which are 
known to be associated with TLR4 on the cell surface as co-receptors for bacterial LPS. 
On the other hand, FADD, MAPK3 and MAP2K1 are downstream regulators of the 
apoptosis pathway and the production of inflammatory cytokines in TLR4 signaling 
(Appendix H). Interestingly, gene-expression analysis revealed that all five of them are 
overexpressed in obesity (ranging from 1.2 to 2.5-fold). Along with the differential 
splicing of the TLR4 gene, these findings support the upregulation of TLR4 signaling in 
obesity, which in turn might contribute to the progression of obesity-related 
inflammation and complications. 
 
The result of the correlation analysis shows that the TV3/TV1 ratios obtained from 
RNA-Seq is much higher than the ratios from RT-qPCR, which is the gold standard in 
gene-expression quantification (Bustin et al., 2009). This is not entirely unexpected as 
taking ratio from isoform read counts (RNA-Seq) will generally be different compared 
to taking ratio from direct mRNA quantification (RT-qPCR), since the former are 
subjected to read-mapping uncertainty.   
 
5.4 Limitations 
For the interpretation of results, the subject matter constraints the study to be 
observational in nature. Although direct results from observational studies are known to 
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be problematic for causal inference (Glass, Goodman, Hernán, & Samet, 2013), they are 
useful for generating hypotheses to be tested. Experimental validation then provides the 
evidence for interpretation in the subject matter context.  
 
Cost considerations and difficulty in obtaining sufficient omental adipose tissue 
biopsies mean that the study had to be cross-sectional and limited to a small sample 
size. The latter could result in low statistical power in differential expression analyses, 
particularly when intra-group variation of gene-expression level is large. In this study, 
optimization of statistical signals was endeavored using a set of carefully thought-out 
inclusion and exclusion criteria. The finding of significant enrichment of obesity-related 
DO terms with the set of mined candidate DEGs in the FunDO analysis suggests that 
the current results are unlikely to be an outcome of chance. 
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CHAPTER 6: CONCLUSION 
 
This study has revealed an aspect of gene-disease association that has not been 
adequately investigated before in obesity. Apart from aberrant gene expression 
associated with perturbation in functions like stress and immune responses, obese 
adipose tissue was found to have a TLR4 splicing pattern that is distinctive from the lean 
counterpart. TLR4 signaling is known to participate in the activation of immune 
response. In obesity and insulin resistance, most, if not all, of alternatively spliced genes 
reported are involved in lipid metabolism and preadipocyte proliferation/differentiation 
(Kaminska & Pihlajamäki, 2013). The finding from this study suggests that alternative 
splicing may be a key player in the development of obesity-associated inflammation in 
adipose tissue. Given the current paucity of available anti-obesity drugs, further 
investigation of the role of mRNA isoforms in adipose immune dysregulation may 
provide a new avenue for the discovery of new molecular therapeutic targets. 
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Quality and quantity of RNA samples used for RNA-Seq 
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APPENDIX D1 
 
The Minimum Information for Publication of Quantitative Real-Time PCR Experiments (MIQE) checklist of this study 
Category Essential item to check Description 
Experimental design Definition of experimental and control groups Obesity was defined as BMI ≥ 30 kg/m2, while leanness was BMI < 26 kg/m2 
Number within each group Five obese and six lean patients 
Sample Description Omental adopose tissue biopsies extracted through laparoscopic abdominal surgeries 
Microdissection or macrodissection Macrodissection 
Processing procedure The tissue was immediately cut into small pieces and placed into the Allprotect Tissue 
Reagent (Qiagen) 
If frozen - how and how quickly? Not applicable 
If fixed - with what, how quickly? Not applicable 
Sample storage conditions and duration (especially for FFPE 
samples) 
If RNA extraction was not performed on the same day, the stabilized tissue would be 
stored at -20 °C 
Nucleic acid extraction Procedure and/or instrumentation Not applicable 
Name of kit and details of any modifications RNA purification was performed using RNeasy Lipid Tissue Mini Kit (Qiagen) 
Details of DNase or RNAse treatment During the extraction, on-column DNase digestion was carried out with RNase-free 
DNase set (Qiagen) 
Contamination assessment (DNA or RNA) No amplification was observed in no-RT controls 
Nucleic acid quantification/instrument and method Quantification done using Nanodrop 2000 (Thermo Scientific) 
RNA integrity method/instrument RNA integrity inspection was performed using 2100 Bioanalyzer RNA 6000 Nano 
Assay (Agilent) 
RIN/RQI or Cq of 3' and 5' transcripts  RNA samples with RIN of 6 or above were used for RT-qPCR 
Inhibition testing (Cq dilutions, spike or other)  Cq dilutions (five dilution series) 
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APPENDIX D1, continued 
Category Essential item to check Description 
Reverse transcription Complete reaction conditions High Capacity RNA-to-cDNA kit (Life Technologies) was used. Every reaction consists of 10 
µl of 2 × RT Buffer, 1 µl of 20 × RT Enzyme Mix, and 9 µl of sample + nuclease-free water 
Priming oligonucleotide (if using GSP) and 
concentration 
Not applicable 
Reverse transcriptase and concentration 20 × MultiScribe MuLV supplied with High Capacity RNA-to-cDNA kit (Life Technologies) 
Temperature and time Step 1 (37 °C, 60 min), step 2 (95 °C, 5 min), and step 3 (4 °C, ∞) 
Cqs with and without RT No amplification was observed in no-RT controls for both assays 
qPCR target information If multiplex, efficiency and LOD of each assay. Not applicable 
Sequence accession number TLR4 TV1 (NM_138554) and TV3 (NM_003266) 
Amplicon length Hs01060206_m1: 125 bp; Hs00370853_m1: 68 bp 
In silico specificity screen (BLAST, etc) According to the Taqman website, the assays are specific to its intended target 
Location of each primer by exon or intron (if 
applicable) 
Hs01060206_m1 targets the boundary between exon 1 and 2 of TV1 (NM_138554); 
Hs00370853_m1 targets the boundary between exon 1 and 2 of TV3 (NM_003266) 
What splice variants are targeted? Hs01060206_m1: TV1; Hs00370853_m1: TV3 
qPCR oligonucleotides Primer sequences Not disclosed by the assay manufacturer 
qPCR protocol Complete reaction conditions Each reaction consists of 10 µl of 2 × Taqman Fast Advance Mastermix, 1 µl of 20 × Taqman 
Gene Expression Assay, 2 µl of cDNA template (2 µl), and 7 µl of nuclease-free water 
Reaction volume and amount of cDNA/DNA 20 µl per reaction; 60 ng 
Primer, (probe), Mg++ and dNTP concentrations 20 × primer/probe; the concentrations of Mg2+ and dNTP are not disclosed by the product 
manufacturer 
Polymerase identity and concentration  AmpliTaq Fast DNA Polymerase, in 2 × Taqman Fast Advance Mastermix. 
Buffer/kit identity and manufacturer  Taqman Fast Advance Mastermix (Life Technologies) 
Additives (SYBR Green I, DMSO, etc.) Not applicable 
Complete thermocycling parameters UNG incubation (50 °C, 2 min), polymerase activation (95 °C, 20 s), 40 cycles of PCR: 
denature (95 °C, 10 s), and annealing and extension (60 °C, 30 s) 
Manufacturer of qPCR instrument Qiagen 
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APPENDIX D1, continued 
Category Essential item to check Description 
qPCR validation Specificity (gel, sequence,  melt, or digest) Refer to the gel picture in Appendix D2 
Standard curves with slope and y-intercept Refer to the picture of standard curves in Appendix D2. Each standard curve was determined with 5 
points, 10-fold dilution series run in triplicate 
PCR efficiency calculated from slope Hs01060206_m1: 0.76; Hs00370853_m1: 0.94 
r2 of standard curve Refer to the picture of standard curves in Appendix D2 
Linear dynamic range Hs01060206_m1: three orders of magnitude; Hs00370853_m1: four orders of magnitude 
Cq variation at lower limit LOD measurements were not necessary for this study 
Evidence for limit of detection  LOD measurements were not necessary for this study 
Data analysis qPCR analysis program (source, version) Rotor-Gene Q Series Software version 2.2.3 (Build 11) (Qiagen) 
Cq method determination Quantitation Analysis Cycling A. Green 
Outlier identification and disposition Not applicable 
Results of NTCs  No Cq observed in NTCs of both assays 
Justification of number and choice of reference 
genes 
Not applicable 
Description of normalization method Not applicable 
Number and stage (RT or qPCR) of technical 
replicates 
In triplicates 
Repeatability (intra-assay variation) For each sample, standard deviation (SD) was used to express the Cq variation between replicates. Refer 
to error bars in the picture of standard curves (Appendix D2) 
Statistical methods for result significance For every patient, the expression of the target isoform was calculated using the formula: expression = 
1/(efficiency + 1)Cq. Partial Spearman correlation was used to detect the significance of correlation 
between TV3/TV1 ratio and BMI of patients, controlling for the effects of gender and age 
Software (source, version) R version 2.15.2  
 
  
61 
 
APPENDIX D2 
 
RT-qPCR validation 
 
 
Gel analysis of PCR amplicons. Ten-µl of PCR amplicons were separated by 
electrophoresis on 2 % w/v agarose gel. Left panel: TV1 amplicon generated by 
Hs01060206_m1 assay; right panel: TV3 amplicon generated by Hs00370853_m1 
assay. 
 
 
Standard curves. Top panel: standard curve for TV1 (Hs01060206_m1) assay; bottom 
panel: standard curve for TV3 (Hs00370853_m1) assay. The data are expressed in mean 
± SD. 
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APPENDIX E 
 
Data used for the partial correlation analysis 
Method Patient TV3* TV1* TV3/TV1 BMI Gender Age 
RNA-Seq Obese 1 0.63 0.24 2.68 38.19 M 36 
Obese 2 0.49 0.42 1.16 49.38 M 26 
Obese 3 0.18 0.56 0.32 33.08 F 55 
Lean 1 0.69 0.17 4.01 21.97 M 46 
Lean 2 0.71 0.21 3.39 22.11 F 35 
Lean 3 0.75 0.19 3.99 23.37 F 56 
Lean 4 0.73 0.19 3.91 24.67 F 46 
RT-qPCR Obese 4 28.04 32.90 1.02 38.95 F 28 
Obese 5 27.00 31.91 1.16 35.08 M 57 
Obese 6 27.16 32.43 1.40 34.72 F 48 
Obese 7 28.05 32.12 0.65 62.36 M 39 
Obese 8 27.22 32.68 1.55 30.73 F 59 
Lean 5 28.41 33.68 1.24 17.80 M 18 
Lean 6 27.76 33.48 1.70 24.32 M 53 
Lean 7 26.83 32.75 2.08 22.09 F 52 
Lean 8 27.91 32.70 0.99 25.77 M 50 
Lean 9 27.59 32.78 1.28 22.77 F 19 
Lean 10 27.22 33.02 1.87 17.95 M 21 
 
* For RNA-Seq analysis, proportion data of TV3 and TV1 are provided for every 
patient; for RT-qPCR analysis, Cq data are provided. 
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APPENDIX F 
 
Top 13 functional clusters enriched by the differentially expressed genes (p-value < 0.05, fold change ≥ 2) 
Cluster (Enrichment score) Category Term p-value FDR (%) 
1 (3.94) GOTERM_BP_ALL GO:0007155~cell adhesion 4.67E-05 0.08 
GOTERM_BP_ALL GO:0022610~biological adhesion 4.76E-05 0.08 
GOTERM_BP_ALL GO:0016337~cell-cell adhesion 6.97E-04 1.15 
2 (2.71) GOTERM_BP_ALL GO:0009605~response to external stimulus 7.77E-08 0.00 
GOTERM_BP_ALL GO:0050896~response to stimulus 9.97E-06 0.02 
GOTERM_BP_ALL GO:0006952~defense response 2.55E-05 0.04 
GOTERM_BP_ALL GO:0006950~response to stress 1.31E-04 0.22 
GOTERM_BP_ALL GO:0009611~response to wounding 1.51E-04 0.25 
GOTERM_BP_ALL GO:0006954~inflammatory response 1.71E-04 0.28 
GOTERM_BP_ALL GO:0002253~activation of immune response 4.75E-04 0.78 
GOTERM_BP_ALL GO:0050778~positive regulation of immune response 8.70E-04 1.43 
GOTERM_BP_ALL GO:0016064~immunoglobulin mediated immune response 2.50E-03 4.06 
GOTERM_BP_ALL GO:0050776~regulation of immune response 2.75E-03 4.46 
GOTERM_BP_ALL GO:0019724~B cell mediated immunity 2.86E-03 4.63 
GOTERM_BP_ALL GO:0045087~innate immune response 3.43E-03 5.53 
GOTERM_BP_ALL GO:0006958~complement activation, classical pathway 3.44E-03 5.55 
GOTERM_BP_ALL GO:0048584~positive regulation of response to stimulus 3.58E-03 5.77 
GOTERM_BP_ALL GO:0002684~positive regulation of immune system process 3.77E-03 6.06 
GOTERM_BP_ALL GO:0002455~humoral immune response mediated by circulating immunoglobulin 4.17E-03 6.69 
GOTERM_BP_ALL GO:0002449~lymphocyte mediated immunity 6.38E-03 10.05 
GOTERM_BP_ALL GO:0016485~protein processing 6.66E-03 10.47 
GOTERM_BP_ALL GO:0002682~regulation of immune system process 7.72E-03 12.04 
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APPENDIX F, continued 
Cluster (Enrichment score) Category Term p-value FDR (%) 
2 (2.71), continued GOTERM_BP_ALL GO:0002250~adaptive immune response 8.89E-03 13.75 
GOTERM_BP_ALL GO:0002460~adaptive immune response based on somatic recombination of immune 
receptors built from immunoglobulin superfamily domains 
8.89E-03 13.75 
GOTERM_BP_ALL GO:0051604~protein maturation 9.46E-03 14.56 
GOTERM_BP_ALL GO:0006959~humoral immune response 9.72E-03 14.92 
GOTERM_BP_ALL GO:0006956~complement activation 9.79E-03 15.03 
GOTERM_BP_ALL GO:0048583~regulation of response to stimulus 1.03E-02 15.80 
GOTERM_BP_ALL GO:0002541~activation of plasma proteins involved in acute inflammatory response 1.04E-02 15.96 
GOTERM_BP_ALL GO:0002443~leukocyte mediated immunity 1.30E-02 19.45 
GOTERM_BP_ALL GO:0051605~protein maturation by peptide bond cleavage 1.30E-02 19.45 
GOTERM_BP_ALL GO:0002252~immune effector process 5.35E-02 59.78 
GOTERM_BP_ALL GO:0002526~acute inflammatory response 8.51E-02 77.07 
3 (2.57) GOTERM_BP_ALL GO:0042330~taxis 4.97E-05 0.08 
GOTERM_BP_ALL GO:0006935~chemotaxis 4.97E-05 0.08 
GOTERM_BP_ALL GO:0040011~locomotion 1.89E-04 0.31 
GOTERM_BP_ALL GO:0007626~locomotory behavior 6.59E-04 1.09 
GOTERM_BP_ALL GO:0042221~response to chemical stimulus 3.99E-03 6.40 
GOTERM_BP_ALL GO:0007610~behavior 1.10E-02 16.69 
GOTERM_BP_ALL GO:0016477~cell migration 2.72E-02 36.65 
GOTERM_BP_ALL GO:0006928~cell motion 2.91E-02 38.70 
GOTERM_BP_ALL GO:0051674~localization of cell 4.43E-02 52.78 
GOTERM_BP_ALL GO:0048870~cell motility 4.43E-02 52.78 
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APPENDIX F, continued 
Cluster (Enrichment score) Category Term p-value FDR (%) 
4 (2.48) GOTERM_MF_ALL GO:0004872~receptor activity 6.90E-05 0.10 
GOTERM_MF_ALL GO:0060089~molecular transducer activity 1.03E-04 0.14 
GOTERM_MF_ALL GO:0004871~signal transducer activity 1.03E-04 0.14 
GOTERM_MF_ALL GO:0004888~transmembrane receptor activity 1.58E-02 19.76 
GOTERM_BP_ALL GO:0007166~cell surface receptor linked signal transduction 1.69E-01 95.37 
GOTERM_MF_ALL GO:0004930~G-protein coupled receptor activity 6.25E-01 100.00 
5 (2.36) GOTERM_BP_ALL GO:0007165~signal transduction 1.17E-03 1.92 
GOTERM_BP_ALL GO:0065007~biological regulation 3.04E-03 4.91 
GOTERM_BP_ALL GO:0050789~regulation of biological process 5.22E-03 8.30 
GOTERM_BP_ALL GO:0050794~regulation of cellular process 1.95E-02 27.79 
6 (2.36) GOTERM_CC_ALL GO:0005886~plasma membrane 1.68E-04 0.21 
GOTERM_CC_ALL GO:0016020~membrane 1.44E-03 1.81 
GOTERM_CC_ALL GO:0044425~membrane part 1.01E-02 12.05 
GOTERM_CC_ALL GO:0031224~intrinsic to membrane 1.87E-02 21.22 
GOTERM_CC_ALL GO:0016021~integral to membrane 3.64E-02 37.42 
7 (2.05) GOTERM_MF_ALL GO:0005520~insulin-like growth factor binding 1.80E-03 2.46 
GOTERM_BP_ALL GO:0040008~regulation of growth 1.02E-02 15.67 
GOTERM_BP_ALL GO:0001558~regulation of cell growth 1.70E-02 24.68 
GOTERM_MF_ALL GO:0019838~growth factor binding 1.96E-02 23.94 
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APPENDIX F, continued 
Cluster (Enrichment score) Category Term p-value FDR (%) 
8 (1.77) GOTERM_BP_ALL GO:0002253~activation of immune response 4.75E-04 0.78 
GOTERM_BP_ALL GO:0050778~positive regulation of immune response 8.70E-04 1.43 
GOTERM_BP_ALL GO:0002429~immune response-activating cell surface receptor signaling pathway 6.36E-02 66.32 
GOTERM_BP_ALL GO:0002768~immune response-regulating cell surface receptor signaling pathway 7.24E-02 71.20 
GOTERM_BP_ALL GO:0002757~immune response-activating signal transduction 1.04E-01 83.86 
GOTERM_BP_ALL GO:0002764~immune response-regulating signal transduction 1.18E-01 87.49 
9 (1.74) GOTERM_BP_ALL GO:0051239~regulation of multicellular organismal process 3.31E-04 0.55 
GOTERM_BP_ALL GO:0050793~regulation of developmental process 1.19E-02 18.02 
GOTERM_BP_ALL GO:0045595~regulation of cell differentiation 1.52E-02 22.43 
GOTERM_BP_ALL GO:0048518~positive regulation of biological process 2.06E-02 29.12 
GOTERM_BP_ALL GO:0048522~positive regulation of cellular process 1.63E-01 94.79 
GOTERM_BP_ALL GO:0051094~positive regulation of developmental process 1.71E-01 95.53 
10 (1.71) GOTERM_BP_ALL GO:0007229~integrin-mediated signaling pathway 8.54E-04 1.40 
GOTERM_BP_ALL GO:0007159~leukocyte adhesion 3.11E-03 5.03 
GOTERM_CC_ALL GO:0043235~receptor complex 9.15E-03 10.97 
GOTERM_BP_ALL GO:0030593~neutrophil chemotaxis 1.52E-02 22.34 
GOTERM_BP_ALL GO:0016477~cell migration 2.72E-02 36.65 
GOTERM_BP_ALL GO:0051674~localization of cell 4.43E-02 52.78 
GOTERM_BP_ALL GO:0048870~cell motility 4.43E-02 52.78 
GOTERM_BP_ALL GO:0030595~leukocyte chemotaxis 5.80E-02 62.78 
GOTERM_BP_ALL GO:0060326~cell chemotaxis 6.36E-02 66.32 
GOTERM_BP_ALL GO:0050900~leukocyte migration 1.21E-01 88.28 
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APPENDIX F, continued 
Cluster (Enrichment score) Category Term p-value FDR (%) 
11 (1.69) GOTERM_CC_ALL GO:0044459~plasma membrane part 8.90E-03 10.68 
GOTERM_CC_ALL GO:0031226~intrinsic to plasma membrane 2.60E-02 28.35 
GOTERM_CC_ALL GO:0005887~integral to plasma membrane 3.75E-02 38.26 
12 (1.47) GOTERM_BP_ALL GO:0032501~multicellular organismal process 5.98E-03 9.45 
GOTERM_BP_ALL GO:0032502~developmental process 9.26E-03 14.28 
GOTERM_BP_ALL GO:0007275~multicellular organismal development 1.27E-02 19.14 
GOTERM_BP_ALL GO:0048513~organ development 4.12E-02 50.17 
GOTERM_BP_ALL GO:0009653~anatomical structure morphogenesis 4.75E-02 55.30 
GOTERM_BP_ALL GO:0048856~anatomical structure development 4.99E-02 57.11 
GOTERM_BP_ALL GO:0048869~cellular developmental process 8.63E-02 77.55 
GOTERM_BP_ALL GO:0030154~cell differentiation 9.31E-02 80.17 
GOTERM_BP_ALL GO:0048731~system development 9.76E-02 81.72 
13 (1.44) GOTERM_BP_ALL GO:0045761~regulation of adenylate cyclase activity 3.47E-03 5.59 
GOTERM_BP_ALL GO:0031279~regulation of cyclase activity 3.96E-03 6.35 
GOTERM_BP_ALL GO:0030817~regulation of cAMP biosynthetic process 4.31E-03 6.90 
GOTERM_BP_ALL GO:0051339~regulation of lyase activity 4.31E-03 6.90 
GOTERM_BP_ALL GO:0030814~regulation of cAMP metabolic process 4.68E-03 7.48 
GOTERM_BP_ALL GO:0030808~regulation of nucleotide biosynthetic process 6.18E-03 9.75 
GOTERM_BP_ALL GO:0030802~regulation of cyclic nucleotide biosynthetic process 6.18E-03 9.75 
GOTERM_BP_ALL GO:0030799~regulation of cyclic nucleotide metabolic process 6.91E-03 10.84 
GOTERM_BP_ALL GO:0006140~regulation of nucleotide metabolic process 7.70E-03 12.01 
GOTERM_BP_ALL GO:0007188~G-protein signaling, coupled to cAMP nucleotide second messenger 1.25E-02 18.76 
GOTERM_BP_ALL GO:0019933~cAMP-mediated signaling 1.81E-02 26.10 
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APPENDIX F, continued 
Cluster (Enrichment score) Category Term p-value FDR (%) 
13 (1.44), continued GOTERM_BP_ALL GO:0007187~G-protein signaling, coupled to cyclic nucleotide second messenger 3.35E-02 43.12 
GOTERM_BP_ALL GO:0050790~regulation of catalytic activity 3.37E-02 43.30 
GOTERM_BP_ALL GO:0019932~second-messenger-mediated signaling 3.85E-02 47.78 
GOTERM_BP_ALL GO:0044093~positive regulation of molecular function 4.61E-02 54.24 
GOTERM_BP_ALL GO:0019935~cyclic-nucleotide-mediated signaling 4.89E-02 56.38 
GOTERM_BP_ALL GO:0043085~positive regulation of catalytic activity 4.89E-02 56.39 
GOTERM_BP_ALL GO:0065009~regulation of molecular function 4.97E-02 57.01 
GOTERM_BP_ALL GO:0007189~activation of adenylate cyclase activity by G-protein signaling pathway 6.65E-02 68.00 
GOTERM_BP_ALL GO:0010578~regulation of adenylate cyclase activity involved in G-protein signaling 6.65E-02 68.00 
GOTERM_BP_ALL GO:0010579~positive regulation of adenylate cyclase activity by G-protein signaling pathway 6.65E-02 68.00 
GOTERM_BP_ALL GO:0007194~negative regulation of adenylate cyclase activity 1.15E-01 86.65 
GOTERM_BP_ALL GO:0007190~activation of adenylate cyclase activity 1.15E-01 86.65 
GOTERM_BP_ALL GO:0031280~negative regulation of cyclase activity 1.15E-01 86.65 
GOTERM_BP_ALL GO:0051350~negative regulation of lyase activity 1.15E-01 86.65 
GOTERM_BP_ALL GO:0045762~positive regulation of adenylate cyclase activity 1.18E-01 87.49 
GOTERM_BP_ALL GO:0031281~positive regulation of cyclase activity 1.21E-01 88.28 
GOTERM_BP_ALL GO:0051349~positive regulation of lyase activity 1.29E-01 89.74 
GOTERM_BP_ALL GO:0044092~negative regulation of molecular function 1.42E-01 92.13 
GOTERM_BP_ALL GO:0043086~negative regulation of catalytic activity 1.69E-01 95.37 
GOTERM_BP_ALL GO:0007186~G-protein coupled receptor protein signaling pathway 5.26E-01 100.00 
GOTERM_MF_ALL GO:0004930~G-protein coupled receptor activity 6.25E-01 100.00 
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APPENDIX G 
 
Differentially spliced genes passing the specified cutoff (p-value < 0.1 and absolute 
splicing index > 0.25) 
No. Gene 
Symbol 
Description Affected isoform* Splicing 
index 
1 ARHGAP26 Rho GTPase activating protein 26 NM_001135608 0.26 
2 BMX BMX non-receptor tyrosine kinase NM_203281 > 0.25 
3 C17orf58 Chromosome 17 open reading frame 58 NM_181656 0.28 
NM_181655 -0.29 
4 CACNB3 Calcium channel, voltage-dependent, beta 3 
subunit 
NM_001206916 -0.26 
NM_001206917 0.27 
5 CHST12 Carbohydrate (chondroitin 4) sulfotransferase 
12 
NM_001243794 -0.28 
6 CLCN2 Chloride channel, voltage-sensitive 2 NM_004366 -0.30 
7 COCH Coagulation factor C homolog, cochlin (Limulus 
polyphemus) 
NM_001135058 -0.31 
NM_004086 0.27 
8 DCLK2 Doublecortin-like kinase 2 NR_036614 > 0.25 
9 DUS4L Dihydrouridine synthase 4-like (S. cerevisiae) NR_073002 0.31 
10 FAIM3 Fas apoptotic inhibitory molecule 3 NM_005449 0.40 
11 FAM109A Family with sequence similarity 109, member A NM_001177996 0.33 
12 FCHO1 FCH domain only 1 NM_001161359 -0.29 
13 GDPD1 Glycerophosphodiester phosphodiesterase 
domain containing 1 
NM_001165993 > 0.25 
14 GLRB Glycine receptor, beta NM_000824 -0.31 
15 GRB7 Growth factor receptor-bound protein 7 NM_005310 0.32 
16 IGF2BP2 Insulin-like growth factor 2 mRNA binding 
protein 2 
NM_006548 0.29 
17 IKZF3 IKAROS family zinc finger 3 (Aiolos) NR_047561 -0.32 
18 IL12RB2 Interleukin 12 receptor, beta 2 NM_001559 0.44 
19 L1CAM L1 cell adhesion molecule NM_000425 -0.26 
20 LAT2 Linker for activation of T cells family, member 2 NM_032464 0.35 
21 LRRC20 Leucine rich repeat containing 20 NM_001278212 -0.30 
22 MARCH1 Membrane-associated ring finger (C3HC4) 1, 
E3 ubiquitin protein ligase 
NM_017923 0.33 
23 MID1 Midline 1 (Opitz/BBB syndrome) NM_033290 > 0.25 
24 MIPOL1 Mirror-image polydactyly 1 NM_138731 0.40 
 
* Difference in medians between the obese and lean groups was analyzed using the 
Mann-Whitney U test; p-values for all isoforms listed are 0.06. It is possible to observe 
identical p-values because the Mann-Whitney U test uses rankings (instead of original 
values) to compute a p-value. 
  
70 
 
APPENDIX G, continued 
No. Gene Symbol Description Affected isoform* Splicing 
index 
25 MRPL24 Mitochondrial ribosomal protein L24 NM_024540 0.26 
NM_145729 -0.26 
26 MSANTD3 Myb/SANT-like DNA-binding domain 
containing 3 
NM_001198805 -0.36 
27 MYBL1 V-myb myeloblastosis viral oncogene 
homolog (avian)-like 1 
NM_001080416 0.39 
28 PCDH19 Protocadherin 19 NM_001105243 0.27 
29 PIGC Phosphatidylinositol glycan anchor 
biosynthesis, class C 
NM_002642 0.36 
NM_153747 -0.37 
30 PLA1A phospholipase A1 member A NM_001206961 0.40 
31 PROX1 Prospero homeobox 1 NM_002763 -0.46 
NM_001270616 0.46 
32 RFX2 Regulatory factor X, 2 (influences HLA 
class II expression) 
NM_134433 0.30 
33 SCN3A Sodium channel, voltage-gated, type III, 
alpha subunit 
NM_001081676 -0.33 
34 SLC25A22 Solute carrier family 25 (mitochondrial 
carrier: glutamate), member 22 
NM_024698 -0.36 
35 TLR4 Toll-like receptor 4 NM_003266 -0.29 
36 TMEM254-AS1 TMEM254 antisense RNA 1 NR_027428 0.34 
37 TMEM51 Transmembrane protein 51 NM_018022 < -0.25 
38 TNFRSF11A Tumor necrosis factor receptor 
superfamily, member 11a, NFKB 
activator 
NM_001270951 -0.27 
39 TOR1AIP1 Torsin A interacting protein 1 NM_015602 -0.33 
NM_001267578 0.35 
40 TRIM55 Tripartite motif containing 55 NM_184086 0.36 
41 WISP1 WNT1 inducible signaling pathway 
protein 1 
NM_003882 0.32 
42 ZFAT Zinc finger and AT hook domain 
containing 
NM_020863 -0.33 
43 ZNF155 Zinc finger protein 155 NM_001260488 -0.29 
44 ZNF180 Zinc finger protein 180 NM_013256 0.27 
45 ZNF273 Zinc finger protein 273 NM_021148 -0.30 
46 ZNF566 Zinc finger protein 566 NM_001145345 -0.42 
47 ZNF583 Zinc finger protein 583 NM_001159860 < -0.25 
NM_152478 0.52 
48 ZNF707 Zinc finger protein 707 NM_173831 -0.29 
49 ZNF85 Zinc finger protein 85 NM_001256171 -0.30 
 
* Difference in medians between the obese and lean groups was analyzed using the 
Mann-Whitney U test; p-values for all isoforms listed are 0.06. It is possible to observe 
identical p-values because the Mann-Whitney U test uses rankings (instead of original 
values) to compute a p-value.  
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APPENDIX H 
 
Pathway analysis of toll-like receptor signaling with differentially expressed genes (p-value < 0.05) 
 
Differentially expressed genes involved in the TLR4 signaling are indicated by asterisks (*); the rectangular portion of this figure is enlarged for better 
viewing on next page. 
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APPENDIX H, continued 
 
 
Differentially expressed genes involved in the TLR4 signaling are indicated by asterisks (*) 
